Elsevier appoints Stuart Whayman as President of Corporate Markets
2025年1月14日
Mr. Whayman’s previous leadership roles at the company include serving as Chief Financial Officer, Chief Commercial Officer and Managing Director of the Researchers and Librarians business segment
Elsevier, a global leader in scientific information and analytics, announced today the appointment of Stuart Whayman as President of Corporate Markets effective January 6, 2025. Mr. Whayman will report to Kumsal Bayazit, CEO of Elsevier, and will lead the global business that provides advanced scientific and technical information, data and decision support solutions for innovation to R&D-focused organizations across various industries, including pharmaceuticals and chemicals.
Mr. Whayman joined Elsevier in 2014, initially as Chief Financial Officer and later served as Chief Commercial Officer. Most recently he was Managing Director of the Researchers and Librarians business segment, leading a cross-functional global team supporting academic research institutions. He played a key role in developing new innovative solutions for researchers, combining generative AI, trusted content, and data sets. He previously held senior roles in finance at RELX, Elsevier’s parent company, and at RBI, now part of the LexisNexis Risk division, having joined the group in 1998.
Kumsal Bayazit, CEO of Elsevier, said: “Stuart brings exceptional global leadership experience and a proven track record of driving positive outcomes for our customers. His deep knowledge of combining trusted content and data sets with responsible technologies and AI is invaluable during this time of accelerated technological change in the R&D environment.”
In addition to his commercial and management responsibilities, Stuart will continue to serve as the Executive Sponsor of our Climate Action Program and as Co-Chair of Elsevier’s Climate Advisory Board.
關於 Elsevier
身為科學資訊與分析的全球領導者,Elsevier 協助研究人員與醫療照護專業人員推動科學發展,改善醫療成果,造福社會。我們以可信賴、以實證為基礎的內容和先進的 AI 數位技術為基礎,透過創新的解決方案促進洞察力和關鍵決策。
140 多年來,我們一直為研究和醫療保健界的工作提供支援。我們全球 9,500 名員工,包括 2,500 名技術人員,致力於支援研究人員、圖書館館長、學術領袖、資金提供者、政府、研發密集型公司、醫生、護士、未來醫療保健專業人員和教育工作者的重要工作。我們的 2,900 種科學期刊和經典參考工具書包括其領域中最重要的書籍,包括 Cell Press、The Lancet 和 Gray's Anatomy。 我們與愛思唯爾基金會 (Elsevier Foundation 打開新的分頁/視窗) 合作,與我們服務的社群攜手合作,在發展中國家和世界各地的科學、研究和醫療保健領域推動包容性和多樣性。 Elsevier 是 RELX 打開新的分頁/視窗 的一部分,RELX 打開新的分頁/視窗 是一家為專業和商業客戶提供以資訊為基礎的分析和決策工具的全球供應商。有關我們的工作、數位解決方案和內容的更多資訊,請造訪 www.elsevier.com 。